311 filings
Page 3 of 16
4
u1js boh9s
19 Feb 20
Aeglea BioTherapeutics / Charles N York II ownership change
5:15pm
4
6bfp mqdwuddi07x8f
19 Feb 20
Aeglea BioTherapeutics / Leslie Sloan ownership change
5:14pm
4
8q2fns qplrolv
19 Feb 20
Aeglea BioTherapeutics / Madduri Ravin Rao ownership change
5:14pm
4
2o4qov6 mnuuj8jumjhm
19 Feb 20
Aeglea BioTherapeutics / Anthony G. Quinn ownership change
5:13pm
4
an0lucub
19 Feb 20
Aeglea BioTherapeutics / Jr. Michael Conick Hanley ownership change
5:12pm
SC 13G/A
pedt3q
14 Feb 20
Aeglea BioTherapeutics, Inc.
4:14pm
SC 13G/A
h6fygn0vc4lo5t5wje8c
14 Feb 20
Beneficial ownership report (amended)
12:00pm
SC 13G/A
y7g5c 5lbh
13 Feb 20
Beneficial ownership report (amended)
4:27pm
SC 13G/A
bb2y7doobpzjj yo835w
13 Feb 20
Beneficial ownership report (amended)
4:17pm
SC 13G/A
mtk ge7ra7we
12 Feb 20
Beneficial ownership report (amended)
4:12pm
SC 13G/A
7as ohgpwtw5abwpkq
6 Feb 20
Beneficial ownership report (amended)
2:01pm
SC 13G/A
smmte1wnp5wec1
5 Feb 20
Beneficial ownership report (amended)
12:00am
SC 13G/A
1jxry80
3 Feb 20
Beneficial ownership report (amended)
2:43pm
SC 13G/A
pr1xx8svwwnz p5
30 Jan 20
Beneficial ownership report (amended)
4:12pm
8-K/A
wjd zcx4q3eibw
13 Jan 20
Regulation FD Disclosure
5:20pm
8-K
is3x 53cr7
13 Jan 20
Company Expects to Initiate a Phase 1/2 Trial in the Second Quarter of 2020
7:01am
8-K
8d0o7qte8ovad9
3 Dec 19
Regulation FD Disclosure
8:00am
8-K
2pid79j649jf1raac
6 Nov 19
Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
8:30am
4
j6t7ehjfm 5usoej
4 Nov 19
Aeglea BioTherapeutics / Madduri Ravin Rao ownership change
5:21pm